Short answer
Cardinal Health (CAH) filed an 8-K current report with the SEC on April 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Cardinal Health reported results for the quarter ended March 31, 2026.
Cardinal Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Cardinal Health reported results for the quarter ended March 31, 2026
- Exhibit 99.1 contains the company’s earnings release and detailed financial results
Item 7.01 · Regulation FD Disclosure
- Management webcast scheduled for April 30, 2026 at 8:30 a.m. Eastern
- Discussion covers quarter ended March 31, 2026 results and fiscal-year 2026 outlook
- Presentation and audio replay available through Cardinal Health’s investor-relations website
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue rose 11% to $60.9B, while non-GAAP EPS increased 35% to $3.17, signaling strong underlying operating momentum
- GAAP EPS fell 20% to $1.69 after a $184M Navista & ION goodwill impairment, highlighting execution and valuation risk in that business
- Pharmaceutical and Specialty Solutions profit increased 18% to $784M, the primary driver of quarterly performance
- FY26 non-GAAP EPS guidance raised to $10.70–$10.80, with adjusted free cash flow outlook increased to $3.3B–$3.7B
- Capital returns continued with $1.0B fiscal-year share repurchases and leverage reduced to 3.0x within the 2.75x–3.25x target range
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardinal Health 8-K filings
Get the next CAH 8-K as it lands
Follow CAH for push alerts, or ask the research agent what this filing means.